Diagnosis, course and management of hypersensitivity pneumonitis
M Hamblin, H Prosch… - European Respiratory …, 2022 - Eur Respiratory Soc
Hypersensitivity pneumonitis (HP) is a complex and heterogeneous interstitial lung disease
(ILD) that occurs when susceptible individuals develop an exaggerated immune response to …
(ILD) that occurs when susceptible individuals develop an exaggerated immune response to …
Acute exacerbation of interstitial lung disease associated with rheumatic disease
F Luppi, M Sebastiani, C Salvarani… - Nature Reviews …, 2022 - nature.com
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …
[HTML][HTML] Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial
Background The primary analysis of the INBUILD trial showed that in subjects with
progressive fibrosing interstitial lung diseases (ILDs), nintedanib slowed the decline in …
progressive fibrosing interstitial lung diseases (ILDs), nintedanib slowed the decline in …
Immunomodulatory treatment of interstitial lung disease
L van den Bosch, F Luppi, G Ferrara… - … in Respiratory Disease, 2022 - journals.sagepub.com
Interstitial lung diseases (ILDs) other than idiopathic pulmonary fibrosis (IPF) have an array
of immunomodulatory treatment options compared with IPF, due to their inflammatory …
of immunomodulatory treatment options compared with IPF, due to their inflammatory …
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model
H Hozumi, M Kono, H Hasegawa, S Kato, Y Inoue… - Respiratory …, 2022 - Springer
Background Patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD),
like those with idiopathic pulmonary fibrosis (IPF), might develop an unexpected acute …
like those with idiopathic pulmonary fibrosis (IPF), might develop an unexpected acute …
Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis
M Xie, C Zhu, Y Ye - BMC Pulmonary Medicine, 2023 - Springer
Introduction Acute exacerbation (AE) is a devastating complication of rheumatoid arthritis-
associated interstitial lung disease (RA-ILD) and leads to high mortality. This study aimed to …
associated interstitial lung disease (RA-ILD) and leads to high mortality. This study aimed to …
Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes
Background Patients with fibrotic hypersensitivity pneumonitis (HP) show variable clinical
courses, and some experience rapid deterioration (RD), including acute exacerbation (AE) …
courses, and some experience rapid deterioration (RD), including acute exacerbation (AE) …
Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways
Idiopathic pulmonary fibrosis (IPF) is the most common fibrotic form of idiopathic diffuse lung
disease. Due to limited treatment options, IPF patients suffer from poor survival. About ten …
disease. Due to limited treatment options, IPF patients suffer from poor survival. About ten …
COVID-19 and acute exacerbation of interstitial lung disease
Y Kondoh, K Kataoka, M Ando, Y Awaya… - Respiratory …, 2021 - Elsevier
We conducted a study to examine the effect of COVID-19 on the acute exacerbation of
interstitial lung disease (AE-ILD) early in the COVID-19 epidemic (January 1–April 30 …
interstitial lung disease (AE-ILD) early in the COVID-19 epidemic (January 1–April 30 …